20 (AIDX) Assets (2024 - 2026)

20's (AIDX) quarterly Assets came in at $5.8 million in Q1 2026, up 40.27% on a QoQ basis from $4.1 million in Q4 2025.

20 (AIDX) Assets (2024 - 2026) Analysis & Trends

20 (AIDX) has 3 years of Assets data on file, last reported at $5.8 million in Q1 2026.

Quarterly Assets changed N/A year-over-year to $5.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.8 million (changed N/A YoY) and the FY2025 annual result came in at $4.1 million, up 15.43% from the prior year.
Assets advanced to $5.8 million in Q1 2026, from $4.1 million in the prior quarter.
In the past five years, Assets ranged from a high of $5.8 million in Q1 2026 to a low of $3.6 million in Q4 2024.
A 3-year average of $4.5 million and a median of $4.1 million in 2025 frame the typical range for Assets.
The widest YoY moves for Assets: up 15.43% in 2025, down 15.43% in 2025.
Tracing AIDX's Assets over 3 years: stood at $3.6 million in 2024, then advanced by 15.43% to $4.1 million in 2025, then soared by 40.27% to $5.8 million in 2026.
The last three Assets figures came in at $5.8 million (Q1 2026), $4.1 million (Q4 2025), and $3.6 million (Q4 2024), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Assets (Qtr)
1	Abbott Laboratories	199.12 Bn	193.52 Bn	7.27 Bn	109.22 Bn
2	Stryker	128.79 Bn	125.32 Bn	4.50 Bn	47.93 Bn
3	Medtronic	119.30 Bn	110.08 Bn	6.41 Bn	93.03 Bn
4	Boston Scientific	73.50 Bn	72.96 Bn	3.85 Bn	45.22 Bn
5	Edwards Lifesciences	52.11 Bn	47.86 Bn	1.35 Bn	13.87 Bn
6	Dexcom	34.62 Bn	32.67 Bn	830.00 Mn	6.46 Bn
7	GE HealthCare Technologies	34.05 Bn	31.94 Bn	2.18 Bn	37.25 Bn
8	Koninklijke Philips	26.42 Bn	23.10 Bn	4.55 Bn	31.04 Bn
9	Steris	23.15 Bn	22.67 Bn	684.20 Mn	10.74 Bn
10	20	5.60 Mn	1.05 Mn	304,727.00	6.12 Mn

Download Data